- Home
- RPRX vs WING Comparison
RPRX vs WING Comparison
Compare RPRX & WING Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- WING
- Stock Information
- Founded
- RPRX 1996
- WING 1994
- Country
- RPRX United States
- WING United States
- Employees
- RPRX N/A
- WING N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- WING Restaurants
- Sector
- RPRX Health Care
- WING Consumer Discretionary
- Exchange
- RPRX Nasdaq
- WING Nasdaq
- Market Cap
- RPRX 11.8B
- WING 11.2B
- IPO Year
- RPRX 2020
- WING 2015
- Fundamental
- Price
- RPRX $26.43
- WING $337.60
- Analyst Decision
- RPRX Strong Buy
- WING Buy
- Analyst Count
- RPRX 6
- WING 17
- Target Price
- RPRX $41.67
- WING $386.71
- AVG Volume (30 Days)
- RPRX 3.1M
- WING 768.6K
- Earning Date
- RPRX 11-06-2024
- WING 10-30-2024
- Dividend Yield
- RPRX 3.18%
- WING 0.32%
- EPS Growth
- RPRX 518.56
- WING 48.72
- EPS
- RPRX 2.55
- WING 3.42
- Revenue
- RPRX $2,266,003,000.00
- WING $591,043,000.00
- Revenue This Year
- RPRX $12.38
- WING $39.32
- Revenue Next Year
- RPRX $11.26
- WING $20.06
- P/E Ratio
- RPRX $10.35
- WING $98.71
- Revenue Growth
- RPRX N/A
- WING 34.98
- 52 Week Low
- RPRX $25.10
- WING $229.27
- 52 Week High
- RPRX $31.66
- WING $433.86
- Technical
- Relative Strength Index (RSI)
- RPRX 45.67
- WING 47.53
- Support Level
- RPRX $25.47
- WING $322.82
- Resistance Level
- RPRX $26.67
- WING $336.27
- Average True Range (ATR)
- RPRX 0.64
- WING 11.60
- MACD
- RPRX 0.05
- WING 3.91
- Stochastic Oscillator
- RPRX 40.80
- WING 77.34
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About WING Wingstop Inc.
Founded in 1994 in Garland, Texas, Wingstop is a restaurant operator specializing in indulgent bone-in and boneless chicken wings, chicken tenders, fries, and, recently, chicken sandwiches. The firm's footprint has grown quickly since its inception, reaching north of 2,200 global stores at the end of 2023, rendering Wingstop the 31st-largest restaurant brand in the US by system sales, according to Euromonitor data. With a 98% franchised model, Wingstop generates the lion share of its revenue from franchise royalties and advertising fees, with the remainder derived from a small footprint of company-owned stores.